Reply to: Beyond S100B: The need for new biomarkers in stage III melanoma recurrence detection.

Eur J Surg Oncol

University of Groningen, University Medical Center Groningen (UMCG), Department of Surgical Oncology, Hanzeplein 1, 9700 RB, Groningen, the Netherlands. Electronic address:

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2024.108542DOI Listing

Publication Analysis

Top Keywords

reply s100b
4
s100b biomarkers
4
biomarkers stage
4
stage iii
4
iii melanoma
4
melanoma recurrence
4
recurrence detection
4
reply
1
biomarkers
1
stage
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!